Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy
- Conditions
- HIV
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- American Gene Technologies International Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05540964
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸Washington Health Institute, Washington, District of Columbia, United States
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T
- Conditions
- HIV
- First Posted Date
- 2022-09-07
- Last Posted Date
- 2022-12-02
- Lead Sponsor
- American Gene Technologies International Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT05529342
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸Washington Health Institute, Washington, District of Columbia, United States
Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy
- Conditions
- HIV
- First Posted Date
- 2020-09-23
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- American Gene Technologies International Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04561258
- Locations
- 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸Washington Health Institute, Washington, District of Columbia, United States
Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals
- Conditions
- HIV Infections
- First Posted Date
- 2017-07-12
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- American Gene Technologies International Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03215004
- Locations
- 🇺🇸
Providence Hospital, Washington, District of Columbia, United States
🇺🇸Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States